Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome

• Status: Terminated
• Trial end date: 2019-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

Corticotherapy accelerates maternal postpartum recovery in women with class I HELLP syndrome. The benefit of faster and better recovery would be observed in fewer complications, less utilization of blood products and shorter hospital stay.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Instituto Materno Infantil Prof. Fernando Figueira
• Treatments: BB 1101; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Postpartum women with Class I HELLP syndrome

Exclusion Criteria:

• Chronic users of corticosteroids

• Patients with chronic conditions affecting the laboratory parameters involved in the HELLP syndrome

• Women who had received antenatal corticosteroids to treat HELLP syndrome were excluded